Original Research

Accepted on 30 Dec 2024

Effect of hyperhomocysteinemia on the prognostic value of triglyceride glucose index in patients with acute coronary syndrome

in Cardiovascular Metabolism

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1517437

132 views

Review

Accepted on 26 Dec 2024

Mechanisms of Inflammatory Microenvironment Formation in Cardiometabolic Diseases: Molecular and Cellular Perspectives

in Cardiovascular Metabolism

Menghua Liu
Rumeng Chen
Zhiwei Zheng
Shuling Xu
Chunyan Hou
Yining Ding
Mengling Zhang
Mei-hua Bao
Binsheng He
Sen Li

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1529903

Systematic Review

Published on 10 Dec 2024

Association between trimethylamine N-oxide and prognosis of patients with myocardial infarction: a meta-analysis

in Cardiovascular Metabolism

Xiuqing Li
Yubao Wang
Jie Xu
Kaili Luo
Tao Dong

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1334730

529 views

Systematic Review

Accepted on 28 Nov 2024

A Systematic Literature Review to Evaluate the Cardiac and Cerebrovascular Outcomes of Patients with Fabry Disease Treated with Agalsidase Beta

in Cardiovascular Metabolism

Gavin Y Oudit
Pronabesh DasMahapatra
Nicole Lyn
Florence R Wilson
Adekemi Adeyemi
Chae Sung Lee
Ana Crespo
Mehdi Namdar

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1415547

112 views

Review

Published on 27 Nov 2024

Lactate metabolism and lactylation in cardiovascular disease: novel mechanisms and therapeutic targets

in Cardiovascular Metabolism

Han Zhang
Jiulu Zhao
Jizhang Yu
Xi Zhang
Shuan Ran
Song Wang
Weicong Ye
Zilong Luo
Xiaohan Li
Yanglin Hao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1489438

1,372 views

Review

Published on 11 Oct 2024

Human and gut microbiota synergy in a metabolically active superorganism: a cardiovascular perspective

in Cardiovascular Metabolism

Matteo Antonio Russo
Matteo Puccetti
Claudio Costantini
Stefano Giovagnoli
Maurizio Ricci
Enrico Garaci
Luigina Romani

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1411306

1,127 views

Review

Published on 01 Oct 2024

Drivers of cardiovascular disease in metabolic dysfunction-associated steatotic liver disease: the threats of oxidative stress

in Cardiovascular Metabolism

Erika T. Minetti
Naomi M. Hamburg
Reiko Matsui

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1469492

2,272 views

Review

Published on 22 Aug 2024

Protein tyrosine phosphatase 1B in metabolic and cardiovascular diseases: from mechanisms to therapeutics

in Cardiovascular Metabolism

Yan Sun
Frank A. Dinenno
Peiyang Tang
Maria I. Kontaridis

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1445739

1,324 views

Original Research

Published on 25 Jul 2024

Serum metabolites and hypercholesterolemia: insights from a two-sample Mendelian randomization study

in Cardiovascular Metabolism

Weitao Wang
Jingwen Qiao
Zhaoyin Su
Hui Wei
Jincan Wu
Yatao Liu
Rubing Lin
Nerich Michael

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1410006

1,387 views

Original Research

Published on 18 Jul 2024

Expression of pro- and anti-inflammatory cytokines during anti-proprotein convertase subtilisin/kexin type 9 therapy in patients with statin-resistant familial hypercholesterolemia

in Cardiovascular Metabolism

Julieta Danira Morales-Portano
Rafael Trujillo-Cortés
Bricia Margarita Roa-Martínez
Rebeca Pérez-Cabeza de Vaca
Silvia García
Paul Mondragón-Terán
Juan A. Suárez-Cuenca

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1417044

1,295 views

Editorial

Published on 17 Jul 2024

Editorial: New discoveries on calcium handling in cardiovascular pathology

in Cardiovascular Metabolism

Andreas Rinne
Jens Kockskämper
Florentina Pluteanu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1461311

742 views

Original Research

Published on 15 Jul 2024

The inotropic and arrhythmogenic effects of acutely increased late INa are associated with elevated ROS but not oxidation of PKARIα

in Cardiovascular Metabolism

Theresa Gissibl
Laura Stengel
Daniel Tarnowski
Lars S. Maier
Stefan Wagner
Anna-Lena Feder
Can Martin Sag

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1379930

1,236 views

Mini Review

Published on 26 Jun 2024

Inflammaging, immunosenescence, and cardiovascular aging: insights into long COVID implications

in Cardiovascular Metabolism

Ludmila Müller
Svetlana Di Benedetto

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1384996

2,814 views
1 citation

Original Research

Published on 25 Jun 2024

Risk factors and prognostic value of endotoxemia in patients with acute myocardial infarction

in Cardiovascular Metabolism

Maxime Nguyen
Alain Putot
David Masson
Yves Cottin
Thomas Gautier
Laura Tribouillard
Anne-Laure Rérole
Pierre-Grégoire Guinot
Maud Maza
Jean-Paul Pais de Barros

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1419001

849 views

Original Research

Published on 10 Jun 2024

Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity

in Cardiovascular Metabolism

Ying Wang
Carolin Ertl
Christina Schmitt
Linda Hammann
Rafaela Kramer
Ulrich Grabmaier
Florian Schöberl
David Anz
Ignazio Piseddu
Giulia Pesch

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1408586

2,691 views
1 citation

Editorial

Published on 31 May 2024

Editorial: Exploiting cellular immunometabolism as a strategy for innovative cardiovascular therapies

in Cardiovascular Metabolism

F. Bonacina
D. Della-Morte

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1435850

659 views

Navigation group

Articles

Effect of hyperhomocysteinemia on the prognostic value of triglyceride glucose index in patients with acute coronary syndrome

Mechanisms of Inflammatory Microenvironment Formation in Cardiometabolic Diseases: Molecular and Cellular Perspectives

Association between trimethylamine N-oxide and prognosis of patients with myocardial infarction: a meta-analysis

A Systematic Literature Review to Evaluate the Cardiac and Cerebrovascular Outcomes of Patients with Fabry Disease Treated with Agalsidase Beta

Lactate metabolism and lactylation in cardiovascular disease: novel mechanisms and therapeutic targets

Human and gut microbiota synergy in a metabolically active superorganism: a cardiovascular perspective

Drivers of cardiovascular disease in metabolic dysfunction-associated steatotic liver disease: the threats of oxidative stress

Protein tyrosine phosphatase 1B in metabolic and cardiovascular diseases: from mechanisms to therapeutics

Serum metabolites and hypercholesterolemia: insights from a two-sample Mendelian randomization study

Expression of pro- and anti-inflammatory cytokines during anti-proprotein convertase subtilisin/kexin type 9 therapy in patients with statin-resistant familial hypercholesterolemia

Editorial: New discoveries on calcium handling in cardiovascular pathology

The inotropic and arrhythmogenic effects of acutely increased late INa are associated with elevated ROS but not oxidation of PKARIα

Inflammaging, immunosenescence, and cardiovascular aging: insights into long COVID implications

Risk factors and prognostic value of endotoxemia in patients with acute myocardial infarction

Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity

Editorial: Exploiting cellular immunometabolism as a strategy for innovative cardiovascular therapies